408 related articles for article (PubMed ID: 29527516)
1. Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia.
Sun Y; Chen BR; Deshpande A
Front Oncol; 2018; 8():41. PubMed ID: 29527516
[TBL] [Abstract][Full Text] [Related]
2. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia.
Gallipoli P; Giotopoulos G; Huntly BJ
Ther Adv Hematol; 2015 Jun; 6(3):103-19. PubMed ID: 26137202
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects.
Gambacorta V; Gnani D; Vago L; Di Micco R
Front Cell Dev Biol; 2019; 7():207. PubMed ID: 31681756
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia.
Lu R; Wang GG
Front Oncol; 2017; 7():241. PubMed ID: 29075615
[TBL] [Abstract][Full Text] [Related]
6. Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.
Castelli G; Pelosi E; Testa U
Onco Targets Ther; 2018; 11():131-155. PubMed ID: 29343972
[TBL] [Abstract][Full Text] [Related]
7. Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia.
Magliulo D; Bernardi R; Messina S
Front Oncol; 2018; 8():255. PubMed ID: 30073149
[TBL] [Abstract][Full Text] [Related]
8. [Genetic abnormalities in AML].
Nakajima H
Rinsho Ketsueki; 2019; 60(6):584-593. PubMed ID: 31281149
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation as a pathogenic event and as a therapeutic target in AML.
Schoofs T; Müller-Tidow C
Cancer Treat Rev; 2011; 37 Suppl 1():S13-8. PubMed ID: 21612874
[TBL] [Abstract][Full Text] [Related]
10. Functions of RNA N
Zheng X; Gong Y
Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity.
Goldman SL; Hassan C; Khunte M; Soldatenko A; Jong Y; Afshinnekoo E; Mason CE
Front Genet; 2019; 10():133. PubMed ID: 30881380
[TBL] [Abstract][Full Text] [Related]
12. HDAC Inhibitors in Acute Myeloid Leukemia.
San José-Enériz E; Gimenez-Camino N; Agirre X; Prosper F
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31739588
[TBL] [Abstract][Full Text] [Related]
13. Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia.
Wingelhofer B; Somervaille TCP
Front Oncol; 2019; 9():850. PubMed ID: 31552175
[TBL] [Abstract][Full Text] [Related]
14. Current and emerging molecular and epigenetic disease entities in acute myeloid leukemia and a critical assessment of their therapeutic modalities.
Zhao X; Liu HQ; Wang LN; Yang L; Liu XL
Semin Cancer Biol; 2022 Aug; 83():121-135. PubMed ID: 33242577
[TBL] [Abstract][Full Text] [Related]
15. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis.
Eriksson A; Lennartsson A; Lehmann S
Exp Hematol; 2015 Aug; 43(8):609-24. PubMed ID: 26118500
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms in acute myeloid leukemia.
Peters AH; Schwaller J
Prog Drug Res; 2011; 67():197-219. PubMed ID: 21141731
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapies in acute myeloid leukemia: where to from here?
Fennell KA; Bell CC; Dawson MA
Blood; 2019 Nov; 134(22):1891-1901. PubMed ID: 31697822
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
Yang X; Wong MPM; Ng RK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
[TBL] [Abstract][Full Text] [Related]
20. Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
Pennisi R; Albanesi J; Ascenzi P; Nervi C; di Masi A
IUBMB Life; 2018 Nov; 70(11):1057-1066. PubMed ID: 30296357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
